(MUR) Murphy Oil - Ratings and Ratios
Crude Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.25% |
| Yield on Cost 5y | 12.36% |
| Yield CAGR 5y | 26.22% |
| Payout Consistency | 74.6% |
| Payout Ratio | 89.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 48.7% |
| Value at Risk 5%th | 76.6% |
| Relative Tail Risk | -4.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.36 |
| Alpha | -13.23 |
| CAGR/Max DD | -0.13 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.411 |
| Beta | 1.556 |
| Beta Downside | 2.216 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.46% |
| Mean DD | 24.69% |
| Median DD | 22.19% |
Description: MUR Murphy Oil January 11, 2026
Murphy Oil Corporation (NYSE:MUR) is a vertically integrated upstream firm that explores for and produces crude oil, natural gas, and natural gas liquids across the United States, Canada, and select international assets. Founded in 1950 and renamed in 1964, the company is headquartered in Houston, Texas, and trades as a common stock within the GICS sub-industry “Oil & Gas Exploration & Production.”
Key operating metrics as of the latest 2023 annual report show average daily production of roughly 115,000 barrels of oil equivalent (BOE), with a 2022-2023 cash flow conversion of about 1.2 ×, and a net debt-to-EBITDA ratio near 2.0×, indicating moderate leverage relative to peers. The firm’s earnings are highly sensitive to U.S. shale price dynamics and the broader natural-gas market, which is driven by seasonal demand, LNG export capacity, and OPEC-plus production decisions.
If you want to dig deeper into Murphy Oil’s valuation and scenario analysis, the ValueRay platform offers a data-rich toolkit that can help you assess upside and downside risks.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 142.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -12.94 > 1.0 |
| NWC/Revenue: -1.83% < 20% (prev -8.00%; Δ 6.17% < -1%) |
| CFO/TA 0.15 > 3% & CFO 1.43b > Net Income 142.7m |
| Net Debt (1.79b) to EBITDA (1.32b): 1.36 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.7m) vs 12m ago -5.07% < -2% |
| Gross Margin: 37.71% > 18% (prev 0.37%; Δ 3733 % > 0.5%) |
| Asset Turnover: 28.24% > 50% (prev 32.84%; Δ -4.60% > 0%) |
| Interest Coverage Ratio: 2.99 > 6 (EBITDA TTM 1.32b / Interest Expense TTM 117.0m) |
Altman Z'' 3.95
| A: -0.01 (Total Current Assets 807.5m - Total Current Liabilities 857.7m) / Total Assets 9.73b |
| B: 0.69 (Retained Earnings 6.73b / Total Assets 9.73b) |
| C: 0.04 (EBIT TTM 349.5m / Avg Total Assets 9.72b) |
| D: 1.42 (Book Value of Equity 6.35b / Total Liabilities 4.48b) |
| Altman-Z'' Score: 3.95 = AA |
Beneish M -2.73
| DSRI: 1.25 (Receivables 283.7m/263.1m, Revenue 2.75b/3.19b) |
| GMI: 0.99 (GM 37.71% / 37.36%) |
| AQI: 1.57 (AQ_t 0.01 / AQ_t-1 0.00) |
| SGI: 0.86 (Revenue 2.75b / 3.19b) |
| TATA: -0.13 (NI 142.7m - CFO 1.43b) / TA 9.73b) |
| Beneish M-Score: -2.73 = A |
ValueRay F-Score (Strict, 0-100) 47.53
| 1. Piotroski: 4.0pt |
| 2. FCF Yield: 6.61% |
| 3. FCF Margin: 14.76% |
| 4. Debt/Equity: 0.43 |
| 5. Debt/Ebitda: 1.36 |
| 6. ROIC - WACC: -3.45% |
| 7. RoE: 2.77% |
| 8. Revenue Trend: -70.21% |
| 9. EPS Trend: -54.61% |
What is the price of MUR shares?
Over the past week, the price has changed by -6.87%, over one month by +0.73%, over three months by +8.55% and over the past year by +9.44%.
Is MUR a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 13
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the MUR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.1 | -4.8% |
| Analysts Target Price | 30.1 | -4.8% |
| ValueRay Target Price | 33.2 | 5.1% |
MUR Fundamental Data Overview January 22, 2026
P/E Forward = 44.6429
P/S = 1.58
P/B = 0.8473
P/EG = 0.3062
Revenue TTM = 2.75b USD
EBIT TTM = 349.5m USD
EBITDA TTM = 1.32b USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 211.7m USD (from shortTermDebt, last quarter)
Debt = 2.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.79b USD (from netDebt column, last quarter)
Enterprise Value = 6.13b USD (4.34b + Debt 2.22b - CCE 426.0m)
Interest Coverage Ratio = 2.99 (Ebit TTM 349.5m / Interest Expense TTM 117.0m)
EV/FCF = 15.13x (Enterprise Value 6.13b / FCF TTM 405.4m)
FCF Yield = 6.61% (FCF TTM 405.4m / Enterprise Value 6.13b)
FCF Margin = 14.76% (FCF TTM 405.4m / Revenue TTM 2.75b)
Net Margin = 5.20% (Net Income TTM 142.7m / Revenue TTM 2.75b)
Gross Margin = 37.71% ((Revenue TTM 2.75b - Cost of Revenue TTM 1.71b) / Revenue TTM)
Gross Margin QoQ = 66.05% (prev 22.56%)
Tobins Q-Ratio = 0.63 (Enterprise Value 6.13b / Total Assets 9.73b)
Interest Expense / Debt = 1.11% (Interest Expense 24.7m / Debt 2.22b)
Taxrate = 13.79% (78.3m / 567.6m)
NOPAT = 301.3m (EBIT 349.5m * (1 - 13.79%))
Current Ratio = 0.94 (Total Current Assets 807.5m / Total Current Liabilities 857.7m)
Debt / Equity = 0.43 (Debt 2.22b / totalStockholderEquity, last quarter 5.12b)
Debt / EBITDA = 1.36 (Net Debt 1.79b / EBITDA 1.32b)
Debt / FCF = 4.42 (Net Debt 1.79b / FCF TTM 405.4m)
Total Stockholder Equity = 5.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.47% (Net Income 142.7m / Total Assets 9.73b)
RoE = 2.77% (Net Income TTM 142.7m / Total Stockholder Equity 5.16b)
RoCE = 5.31% (EBIT 349.5m / Capital Employed (Equity 5.16b + L.T.Debt 1.43b))
RoIC = 4.58% (NOPAT 301.3m / Invested Capital 6.57b)
WACC = 8.03% (E(4.34b)/V(6.56b) * Re(11.65%) + D(2.22b)/V(6.56b) * Rd(1.11%) * (1-Tc(0.14)))
Discount Rate = 11.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.13%
[DCF Debug] Terminal Value 79.70% ; FCFF base≈908.0m ; Y1≈1.03b ; Y5≈1.39b
Fair Price DCF = 154.4 (EV 23.83b - Net Debt 1.79b = Equity 22.04b / Shares 142.7m; r=8.03% [WACC]; 5y FCF grow 15.37% → 2.90% )
EPS Correlation: -54.61 | EPS CAGR: 0.66% | SUE: 1.37 | # QB: 1
Revenue Correlation: -70.21 | Revenue CAGR: -1.48% | SUE: 1.26 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.44 | Chg30d=-0.081 | Revisions Net=-3 | Analysts=13
EPS next Year (2026-12-31): EPS=1.58 | Chg30d=-0.246 | Revisions Net=-3 | Growth EPS=+30.3% | Growth Revenue=-4.0%
Additional Sources for MUR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle